2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Leukemia
32
Leukemia, Myeloid, Acute
20
Lymphoma
19
Lymphoma, Follicular
18
Breast Neoplasms
18
Congenital Abnormalities
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Mantle-Cell
13
Lymphoma, Large-Cell, Immunoblastic
13
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma, B-Cell, Marginal Zone
13
Carcinoma, Non-Small-Cell Lung
13
Hodgkin Disease
12
Head and Neck Neoplasms
12
Burkitt Lymphoma
12
Lymphoma, Non-Hodgkin
11
Colonic Neoplasms
11
Multiple Myeloma
10
Lung Neoplasms
10
Leukemia, Myeloid, Chronic-Phase
10
Squamous Cell Carcinoma of Head and Neck
9
Rectal Neoplasms
9
Neuroblastoma
9
Melanoma
9
Lymphoma, T-Cell, Cutaneous
9
Colorectal Neoplasms
9
Sezary Syndrome
8
Sarcoma
8
Myeloproliferative Disorders
8
Interventions
Cisplatin
116
Radiotherapy
84
Paclitaxel
77
Fluorouracil
62
Carboplatin
41
Drug Therapy
38
pembrolizumab
33
Irinotecan
33
tislelizumab
27
Docetaxel
26
Neoadjuvant Therapy
24
Oxaliplatin
23
toripalimab
22
sintilimab
19
camrelizumab
19
Radiation
19
Esophagectomy
18
Capecitabine
17
130-nm albumin-bound paclitaxel
17
Surgical Procedures, Operative
16
Nivolumab
16
Leucovorin
15
Cetuximab
14
TP protocol
12
S 1 (combination)
12
Radiotherapy, Intensity-Modulated
12
Albumin-Bound Paclitaxel
12
nimotuzumab
11
apatinib
10
Immune Checkpoint Inhibitors
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Polymerase Chain Reaction
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled